The Prime Minister of India, Shri Narendra Modi and the President of Indonesia, Mr Prabowo Subianto witnessed the Exchange of a Memorandum of Understanding (MoU) between India and Indonesia on January 25, 2025, at Hyderabad House, in New Delhi.
One of the MoUs exchanged between India and Indonesia is in the Field of Traditional Medicine Quality Assurance between the Pharmacopoeia Commission for Indian Medicine & Homeopathy, the Ministry of Ayush and the Indonesian Food and Drug Authority.
Highlighting the importance of the MoU exchanged between India and Indonesia in the Field of Traditional Medicine Quality Assurance between Pharmacopoeia Commission for Indian Medicine & Homeopathy, Ministry of Ayush and Indonesian Food and Drug Authority on 25.01.2025, the Union Minister of State (Independent Charge), Ministry of Ayush, Shri Prataprao Jadhav said that the MoU is set to elevate global standards.
PM Shri Narendra Modi and the President of Indonesia, Mr. Prabowo Subianto witnessing the Exchange of MoUs between India and Indonesia at Hyderabad House, in New Delhi, on January 25, 2025
Further highlighting the significance of the MoU, Shri Prataprao Jadhav stated “This collaboration will play a crucial role in ensuring the safety, efficacy, and quality of traditional medicines, setting the stage for a more integrated and scientifically-regulated approach to this valuable healthcare system.”
Underlining the key features of the MoU, the Secretary, Ministry of Ayush, Vaidya Rajesh Kotecha stated, “Through this strategic collaboration, we are fostering greater knowledge exchange, capacity building, and strengthening the role of traditional medicine in global healthcare. Pharmacopoeia Commission for Indian Medicine & Homeopathy (PCIM&H) is an IS/ISO 9001:2015 certified institution for Quality Management Systems (QMS) dedicated to establishing and maintaining standards for Indian medicine and homoeopathy. This partnership between the premier institutions will significantly benefit all stakeholders.
This strategic partnership focuses on fostering collaboration in traditional medicine quality assurance, with both parties committing to various forms of cooperation. Key provisions of the MoU include:
- Exchange of information and expertise on regulatory provisions for traditional medicine.
- Capacity-building initiatives such as seminars, workshops, and training programs aimed at enhancing professional knowledge and skills.
- Technical visits to facilitate familiarisation with the regulatory processes of both countries.
- Joint participation in international events related to traditional medicine.
- Collaboration on joint training programs for industries or entities involved in the traditional medicine sector.
- Expansion of cooperation into other mutually agreed areas.
This collaboration reflects the growing global recognition of traditional medicine’s importance in healthcare and wellness. With its deep-rooted cultural and medicinal heritage, India and Indonesia are committed to advancing the standards and quality of traditional medicine.
The MoU also signifies a shared vision for ensuring the safety, efficacy, and accessibility of traditional medicine, paving the way for further collaboration between India and Indonesia and setting an example for other nations in embracing the integration of traditional systems of medicine within modern healthcare frameworks.
Notably, the MoU exchanged on 25.01.2025 in the presence of the Prime Minister of India and the President of Indonesia by the Minister of External Affairs, Government of India, and the Ministry of External Affairs, Republic of Indonesia, marks a historic milestone in the bilateral relations between the two nations.
This partnership between India and Indonesia highlights the importance of both nations working together to preserve and innovate within their rich medicinal traditions, contributing to the growing recognition and acceptance of traditional medicine globally.
